An early Fountain Partners’ client, SkinCure Oncology announced a $30M growth equity round with Seacoast Capital on September 24, 2019. SkinCure’s turnkey model for the delivery of Image-guided Superficial Radiation Therapy (IG-SRT) has proven to be a great fit with quality-focused dermatologists and Mohs surgeons. By working with physician partners, SkinCure is able to bring cancer center level radiation therapy for the treatment of non-melanoma skin cancers to local doctor’s offices. SkinCure Oncology has facilitated the treatment of more image guided superficial radiation therapy patients than any other group in the world.
